Lilian Rumi Tsuruta

Papers

Total Citations

H-Index

About

Lilian Rumi Tsuruta is a biotechnologist whose work centers on the development and characterization of therapeutic monoclonal antibodies, with a particular focus on biosimilar production platforms. Her most cited study, published in 2018, describes the creation of a novel Chinese hamster ovary (CHO)-derived cell line engineered to express an anti-TNFα monoclonal antibody with biosimilar potential. This work is foundational for the cost-effective production of biologics used in treating autoimmune diseases such as rheumatoid arthritis. By optimizing cell line development and expression systems, Tsuruta contributes to bridging the gap between innovative therapies and accessible medicine. Her research has garnered attention in the bioprocessing field, with her key paper accumulating 5 citations—a meaningful impact for a specialized area of industrial biotechnology. Tsuruta’s achievements underscore her role in advancing mammalian cell culture technologies and biosimilar development, offering practical solutions for scalable, high-yield antibody manufacturing. Her work continues to inspire researchers seeking to improve therapeutic protein production for global health needs.